Dilantin for IV Use

Rapp Robert P. , Kerege John , Piecoro John J. Jr. : Guidelines for the Administration of Commonly Used IV Drugs, Drug Intell. Clin. Pharm. 7: 38–42 (Jan.) 1973.

King James C. : Guide To Parenteral Admixtures, Cutter Laboratories, Inc., 1973.

Anonymous, Manufacturer's Literature, Dilantin Steri-Vial, Parke-Davis & Co., Detroit, Michigan.

Catania Patrick N. , and King James C. Physicochemical Incompatibilities of Selected Cardiovascular and Psychotherapeutic Agents With Sodium Ethacrynate, Amer J. Hosp. Pharm. 29: 141–146, (Feb.) 1972.

Page R. , and Culver P. : A Syllabus of Laboratory Examinations in Clinical Diagnosis, Revised Edition, Harvard University Press, Cambridge, Mass., 1962, p. 349.

Ibid, p. 351, Brod J. , and Sirota J. H. : The Renal Clearance of Endogenous Creatinine in Man, J. Clin. Invest. 27: 645–654, (Sept.) 1948.

Ibid, p. 351, Miller B. F. , Validity of the Endogenous Creatinine Clearance as a Measure of Glomerular Filtration Rate in the Diseased Human Kidney, J. Clin. Invest. 31: 309–313 (Mar.) 1952.

Edwards K.D.G. , Creatinine Space as a Measure of Total Body Water in Anuric Subjects, Estimated After Single Injection and Hemodialysis, Clin. Sci. 18: 455–464 (Aug.) 1959.

Personal communication, Merck, Sharp & Dohme (Nov.) 1972.